G
The startup has developed a wearable device that utilizes gamma rhythm entrainment to reduce neuroinflammation associated with glaucoma. This non-invasive technology provides patients with a safe and effective alternative to traditional treatments, eliminating the need for medication or surgery.
Updated 3 months ago
Funding
$240K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup has developed a wearable device that utilizes gamma rhythm entrainment to reduce neuroinflammation associated with glaucoma. This non-invasive technology provides patients with a safe and effective alternative to traditional treatments, eliminating the need for medication or surgery.